Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party
GJ Schuurhuis, M Heuser, S Freeman… - Blood, The Journal …, 2018 - ashpublications.org
Measurable residual disease (MRD; previously termed minimal residual disease) is an
independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) that is …
independent, postdiagnosis, prognostic indicator in acute myeloid leukemia (AML) that is …
Chimerism and outcomes after allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning
F Baron, BM Sandmaier - Leukemia, 2006 - nature.com
Allogeneic hematopoietic cell transplantation (HCT) following nonmyeloablative
conditioning has been extensively evaluated in patients with hematologic malignancies who …
conditioning has been extensively evaluated in patients with hematologic malignancies who …
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS
J Loke, N McCarthy, A Jackson, S Siddique… - Blood …, 2023 - ashpublications.org
Allogeneic stem-cell transplant allows for the delivery of curative graft-versus-leukemia
(GVL) in patients with acute myeloid leukemia/myelodysplasia (AML/MDS). Surveillance of T …
(GVL) in patients with acute myeloid leukemia/myelodysplasia (AML/MDS). Surveillance of T …
Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning
We analyzed the kinetics of donor engraftment among various peripheral blood cell
subpopulations and their relationship to outcomes among 120 patients with hematologic …
subpopulations and their relationship to outcomes among 120 patients with hematologic …
Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic …
D Valcárcel, R Martino, D Caballero, J Martin… - Journal of Clinical …, 2008 - ascopubs.org
Purpose Reduced-intensity conditioning (RIC) for allogeneic stem-cell transplantation (allo-
SCT) reduces nonrelapse mortality (NRM). This reduction makes it possible for patients who …
SCT) reduces nonrelapse mortality (NRM). This reduction makes it possible for patients who …
[HTML][HTML] Nonmyeloablative stem cell transplantation is an effective therapy for refractory or relapsed hodgkin lymphoma: results of a spanish prospective cooperative …
I Alvarez, A Sureda, MD Caballero… - Biology of Blood and …, 2006 - Elsevier
We report the results of reduced-intensity conditioning allogeneic stem cell transplantation
(allo-RIC) in patients with advanced Hodgkin lymphoma (HL). Forty patients with relapsed or …
(allo-RIC) in patients with advanced Hodgkin lymphoma (HL). Forty patients with relapsed or …
Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell …
R Martino, R Parody, T Fukuda, J Maertens… - Blood, 2006 - ashpublications.org
In this retrospective study, we analyzed the outcomes of 129 patients who underwent an
allogeneic hematopoietic stem cell transplantation (allo-HSCT) and had a history of …
allogeneic hematopoietic stem cell transplantation (allo-HSCT) and had a history of …
Reduced‐intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: A report from the A cute L …
BACKGROUND Fludarabine plus busulfan (FB) and fludarabine plus melphalan (FM) are 2
widely used reduced‐intensity conditioning (RIC) regimens for allogeneic hematopoietic …
widely used reduced‐intensity conditioning (RIC) regimens for allogeneic hematopoietic …
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation
JA Pérez-Simón, M Díez-Campelo, R Martino… - Blood, 2003 - ashpublications.org
We analyzed the impact of CD34+ cell dose on the outcome of 86 patients undergoing
reduced-intensity conditioning (RIC) allogeneic peripheral blood stem cell transplantation …
reduced-intensity conditioning (RIC) allogeneic peripheral blood stem cell transplantation …
[HTML][HTML] Mixed T lymphocyte chimerism after allogeneic hematopoietic transplantation is predictive for relapse of acute myeloid leukemia and myelodysplastic …
HC Lee, RM Saliba, G Rondon, J Chen… - Biology of Blood and …, 2015 - Elsevier
Chimerism testing after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in
patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) …
patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) …